About
MC3 Cardiopulmonary is a medical device company based in Dexter, Michigan, founded in 1991. The company specializes in developing and commercializing advanced cardiopulmonary technologies, particularly Extracorporeal Membrane Oxygenation (ECMO) systems. Originating from research at the University of Michigan, MC3 aims to create life-saving devices for patients with heart and lung failure. The company designs intelligent, patient-centered medical devices that address critical needs in extracorporeal life support. Their product lineup includes the Nautilus Smart ECMO Module, which features advanced monitoring and control capabilities to enhance patient outcomes during ECMO therapy. MC3 also develops specialized catheter systems and components essential for cardiopulmonary support. MC3 Cardiopulmonary serves hospitals, critical care units, and healthcare providers focused on cardiopulmonary and respiratory care. Their products are utilized in clinical settings to support patients with severe heart and lung conditions. With a dedicated team, MC3 is recognized in the extracorporeal life support research community and is committed to advancing medical technologies that improve patient care.
Technologies
Keywords
Company Information
-
Employees 46
-
Founded 1991
-
Annual Revenue $11066000
Location
2555 Bishop Cir W, Dexter, Michigan, United States, 48130